The Remote Monitoring of Gout Feasibility Study (ReMonit Gout)

Diakonhjemmet Hospital

Status

Enrolling

Conditions

Gout

Treatments

Device: "Urika", a self-management application for patients with gout

Study type

Interventional

Funder types

Other

Identifiers

NCT06211322

23/02662

2023054 (Other Grant/Funding Number)

Details and patient eligibility

About

In this feasibility trial, a digital follow-up treatment strategy with patient self-management app (Urika) and remote monitoring in specialist healthcare for patients with gout will be tested.

Full description

In this feasibility study various outcome measures will be assessed to determine whether the app (Urika) is viable, practical, and useful. The study will include assessments of technical, operational, clinical, and trial aspects of feasibility.

Enrollment

30 estimated patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Male or non-pregnant, non-nursing female >18 years of age at screening
Patients with a clinical diagnosis of gout
Patients who fulfil the American College of Rheumatology (ACR)/EULAR classification criteria
Serum urate level >360 μmol/L at inclusion
Having a smartphone/tablet

Exclusion criteria

Contraindication for urate lowering therapy
Unstable medical conditions (e.g,, uncontrollable hypertension, impaired liver function); known stage 3b or higher chronic kidney disease (estimated glomerular filtration (eGFR) rate/creatinine clearance <45 mL/min); severe infection or gastrointestinal bleed
Major co-morbidities (e.g., malignancies, severe cardiovascular disease, severe diabetes mellitus, severe respiratory diseases)
Psychiatric or mental disorders, alcohol abuse or other substance abuse, language barriers or other factors which makes adherence to the study protocol difficult